z-logo
open-access-imgOpen Access
Viral hepatitis prevalence in patients with active and latent tuberculosis
Author(s) -
Hesam Ahmadi Nooredinvand,
David Connell,
M. Asgheddi,
Mohammed Abdullah,
Marie O’Donoghue,
Louise Campbell,
Melissa Wickremasinghe,
Ajit Lalvani,
Onn Min Kon,
Shahid Khan
Publication year - 2015
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v21.i29.8920
Subject(s) - medicine , hbsag , tuberculosis , immunology , hepatitis b virus , hepatitis b , liver disease , hbcag , serology , liver function , latent tuberculosis , antibody , gastroenterology , virology , virus , mycobacterium tuberculosis , pathology
To assess the prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection and association with drug induced liver injury (DILI) in patients undergoing anti-tuberculosis (TB) therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom